Phase I-II-Projekt

Objective of the Phase I/II working group is the interdisciplinary conception, initiation and coordination of phase I/II studies. The consortium not only conducts investigator initiated, academic studies, but also represents a suitable portal to communicate and coordinate studies initiated by pharmaceutical companies. In addition, an interdisciplinary network has been established to perform an extensive biological study programme.

Due to the participation of a multitude of experienced European study centres, simultaneous recruitment of several trials is feasible.

 

Coordinator: V. Ribrag, Institute Gustave Roussy

 
Corporate Partners - Individual Sponsors
Mon, 30th November 2020
Czernecki Donnelly Award 2021
of the European MCL Network
more news